Discussion on the effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults

被引:0
|
作者
Thiebaut, Rodolphe [1 ,2 ]
Eholie, Serge [3 ]
Dabis, Francois [1 ,2 ]
机构
[1] Univ Bordeaux Segalen, Ctr INSERM Epidemiol Biostat U897, ISPED, F-33076 Bordeaux, France
[2] INSERM, Ctr INSERM Epidemiol Biostat U897, ISPED, Bordeaux, France
[3] Ctr Hosp Univ Treichville, Serv Malad Infect & Trop, Abidjan, Cote Ivoire
关键词
HIV-INFECTED PATIENTS; COUNT; SEROCONVERSION; TUBERCULOSIS; PROGRAMS; AFRICA; TIME;
D O I
10.1097/QAD.0b013e328359ab2f
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:146 / 147
页数:2
相关论文
共 50 条
  • [21] Predictors of Virologic Failure in HIV-1-Infected Adults Receiving First-Line Antiretroviral Therapy in 8 Provinces in China
    Ma, Ye
    Zhao, Decai
    Yu, Lan
    Bulterys, Marc
    Robinson, Matthew L.
    Zhao, Yan
    Dou, Zhihui
    Chiliade, Philippe
    Wei, Xiaoyu
    Zhang, Fujie
    CLINICAL INFECTIOUS DISEASES, 2010, 50 (02) : 264 - 271
  • [22] Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children
    Asbjornsdottir, Kristjana H.
    Hughes, James P.
    Wamalwa, Dalton
    Langat, Agnes
    Slyker, Jennifer A.
    Okinyi, Hellen M.
    Overbaugh, Julie
    Benki-Nugent, Sarah
    Tapia, Kenneth
    Maleche-Obimbo, Elizabeth
    Rowhani-Rahbar, Ali
    John-Stewart, Grace
    AIDS, 2016, 30 (18) : 2835 - 2843
  • [23] Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France
    Breton, G.
    Lewden, C.
    Spire, B.
    Salmon, D.
    Brun-Vezinet, F.
    Duong, M.
    Allavena, C.
    Leport, C.
    Salamon, R.
    HIV MEDICINE, 2007, 8 (03) : 164 - 170
  • [24] Combination antiretroviral therapy in 100 HIV-1-infected pregnant women
    Bucceri, AM
    Somigliana, E
    Matrone, R
    Ferraris, G
    Rossi, G
    Grossi, E
    Vignali, M
    HUMAN REPRODUCTION, 2002, 17 (02) : 436 - 441
  • [25] Reactive arthritis responding to antiretroviral therapy in an HIV-1-infected individual
    Scott, C.
    Brand, A.
    Natha, M.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (05) : 373 - 374
  • [26] Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients
    Collins, Sean E.
    Grant, Philip M.
    Shafer, Robert W.
    DRUGS, 2016, 76 (01) : 75 - 98
  • [27] Modifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients
    Sean E. Collins
    Philip M. Grant
    Robert W. Shafer
    Drugs, 2016, 76 : 75 - 98
  • [28] Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy
    Arenas-Pinto, A.
    AIDS, 2007, 21 (18) : 2455 - 2464
  • [29] Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults
    Laurent, C
    Gueye, NFN
    Ndour, CT
    Gueye, PM
    Diouf, M
    Diakhaté, N
    Kane, NCT
    Lanièce, I
    Ndir, A
    Vergne, L
    Ndoye, I
    Mboup, S
    Sow, PS
    Delaporte, E
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (01) : 14 - 17
  • [30] Evaluation of a 6-Year Highly Active Antiretroviral Therapy in Chinese HIV-1-Infected Patients
    Zhou, Hua-ying
    Zheng, Yu-huang
    He, Yan
    Chen, Zi
    Liu, Meng
    Yin, Wei
    Liu, Chun
    INTERVIROLOGY, 2010, 53 (04) : 240 - 246